Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

News

 

UK’s Practice Plus Group bought by Indian hospital giant Narayana Health

Practice Plus Group (PPG), the UK’s fifth-largest for-profit hospital group by revenue and formerly owned by London private equity firm Bridgepoint, has agreed to sell its hospitals division to Indian healthcare giant Narayana Health for around ~ €215 million.  The deal covers PPG’s secondary care business only, separating it from the group’s Integrated Urgent Care operations, which include NHS 111 contact centres and out-of-hours GP services, and from its Health in Justice division, which provides healthcare within the justice system.
November 6, 2025

Fremman buys Stingray to merge with Amethyst

Two of Europe’s three largest private oncology groups are being merged into a single entity, creating continental Europe’s largest oncology player. Private equity firm Fremman Capital has acquired Stingray, an oncology group with a presence in France and Germany, to merge it with its portfolio company Amethyst, a major pan-European radiotherapy group which already has a presence in seven European countries.
November 6, 2025

FREE BLOG The HBI Top 250 list is coming next week

The HBI Top 250 Healthcare Services Companies ranking will be published next week. It is essential reading for anyone running, investing in, advising, or supplying to healthcare service providers across the EMEA region!
November 6, 2025

Australia’s largest health insurer Medibank buys primary care chain Better Medical

Medibank, the largest private health insurer in Australia, is buying Better Medical, a 61-clinic primary care chain, from private equity firm Livingbridge, for A$159 million (~$103 million). This is part of a wider trend of vertical consolidation by insurers within Australia’s private healthcare market, which is raising concerns amongst many in the sector that it could lead to harmful cost cutting.
November 6, 2025

Inflexion-backed CNX Therapeutics expands specialty pharma platform

CNX Therapeutics, a European specialty pharmaceutical company, has acquired the global rights to Sativex (nabiximols), an oral spray used to treat muscle stiffness and spasms in adults with multiple sclerosis, from Jazz Pharmaceuticals, a US-based biopharmaceutical company focused on oncology and neuroscience. Guy Clark, CEO of CNX Therapeutics, tells HBI the deal strengthens the company’s […]
November 6, 2025

CMA greenlights PHP/Assura merger

The UK’s competition authority (the CMA) has decided to allow the merger of Assura and Primary Healthcare Properties (PHP), the only two major UK healthcare REITs focused on primary care clinics, bringing the creation of a giant primary care REIT holding about £6 billion (~€7 billion) worth of property and about 20% of the UK’s primary care practices one step closer to realisation. 
November 5, 2025

Thermo Fisher buys clinical software company Clario for $9bn

Thermo Fisher, a US life sciences and clinical research company listed on the New York Stock Exchange, has acquired Clario, a US company that provides software for clinical trials, from private equity firms Nordic Capital and Astorg Partners, for around $9 billion.
October 30, 2025
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us